[ad_1] Mark Gillispie, Associated Press Update 9:39 AM CST, Sunday 4 November 2018 On Friday, October 26, 2018, Brad Lander, Clinical Psychologist at the Department of Addiction Medicine at the Wexner Medical …
Read More »Amidst the Addiction Crisis, FDA Approves New Powerful Opioid
[ad_1] Despite the current opioid crisis in the country, the Food and Drug Administration on Friday approved a new opioid drug five to ten times more potent than fentanyl. Dsuvia, manufactured by …
Read More »Ohio is likely to consider the medical pot for opioid addiction
[ad_1] Mark Gillispie, Associated Press Update 9:39 AM CST, Sunday 4 November 2018 On Friday, October 26, 2018, Brad Lander, Clinical Psychologist at the Department of Addiction Medicine at the Wexner Medical …
Read More »FDA approves new powerful opioid
[ad_1] Despite the opioid crisis in the country, the US Food and Drug Administration on Friday approved a new opioid drug five to ten times stronger than fentanyl. Dsuvia, manufactured by AcelRx …
Read More »FDA approves new powerful opioid
[ad_1] (CNN) – Despite the opioid crisis in the country, the US Food and Drug Administration on Friday approved a new opioid drug five to ten times stronger than fentanyl. Dsuvia, manufactured …
Read More »Amidst the Addiction Crisis, FDA Approves New Powerful Opioid
[ad_1] By Debra Goldschmidt, CNN (CNN) – Despite the opioid crisis in the country, the US Food and Drug Administration on Friday approved a new opioid drug five to ten times stronger …
Read More »Powerful new drug Dsuvia sparks fears amid opioid epidemic
[ad_1] A new drug approved by the FDA has caught the attention of those on the front lines of fighting the opioid epidemic. Dsuvia, made by a 13-year-old California-based company, AcelRx Pharmaceuticals, is …
Read More »FDA Approves New Powerful Opioid in "Terrible" Decision
[ad_1] WASHINGTON – The Food and Drug Administration on Friday approved a powerful new opioid, despite strong criticism and accusations that it has bypassed its own advisory process. The new drug, Dsuvia, …
Read More »NIH increases funding for BRAIN initiative to expand opioid study
[ad_1] The National Institutes of Health is once again investing in the BRAIN initiative, which will include new studies on opioids. New funding of $ 220 million for 200 new fellowships has …
Read More »FDA accepts powerful opioid pill as alternative to IV pain reliever
[ad_1] This undated image provided by AcelRx Pharmaceuticals shows the drug Dsuvia from the company. On Friday, November 2, 2018, US regulators announced the approval of the fast-acting, super-potent opioid tablet as …
Read More »